Get started
Author

Won-Seog Kim

Observed name: Kim, Won-Seog
ORCID: 0000-0002-5400-0466
Observed ORCID: 0000-0002-5400-0466
OpenAlex ID: A5031647745
The International Consensus Classification of Mature Lymphoid Neoplasms: a report from the Clinical Advisory Committee
2022 · Elias Campo, Elaine S. Jaffe, et al. · Blood · 1,622
PDF
Composite marginal zone B cell lymphoma and enteropathy-type T cell lymphoma of the stomach: a case report
2008 · Won Kyoung Yun, Young-Hyeh Ko, et al. · European Journal of Gastroenterology & Hepatology · 12
Brentuximab vedotin plus chemotherapy for the treatment of front-line systemic anaplastic large cell lymphoma: subgroup analysis of the ECHELON-2 study at 5 years’ follow-up
2025 · Eva Domingo-Domènech, Barbara Pro, et al. · Blood Cancer Journal · 5
PDF
Sustained clinical benefit of glofitamab plus gemcitabine and oxaliplatin (GemOx) versus rituximab plus GemOx (R-GemOx) in patients with relapsed/refractory (R/R) diffuse large B-cell lymphoma (DLBCL): 3-year follow-up of STARGLO
2025 · Jeremy Abramson, Matthew Ku, et al. · Blood · 3
Glofitamab plus gemcitabine and oxaliplatin (GemOx) vs rituximab (R)-GemOx in patients with relapsed/refractory (R/R) diffuse large B-cell lymphoma (DLBCL): Efficacy and safety in patient subgroups
2025 · Haifaa Abdulhaq, William Townsend, et al. · Blood · 3
Treatment patterns and survival outcomes in patients with Mantle Cell Lymphoma: Interim report of the Asia-Pacific multinational prospective registry study
2025 · Dok Hyun Yoon, Hyungwoo Cho, et al. · Blood · 1
PDF
Clinical outcomes of mature T- and NK-cell lymphomas in hepatitis B virus positive individuals: results from the PETAL Global Consortium
2026 · Colin J. Thomas, Min Jung Koh, et al. · Leukemia & lymphoma/Leukemia and lymphoma
Early time-to-relapse as a predictor of survival in mature T-cell/NK-cell lymphomas: Results from the PETAL consortium
2025 · Mark Sorial, Kenechukwu Aniagboso, et al. · Blood
Prognostic significance of post-treatment EBV clearance and relapse patterns in localized extranodal NK/T-cell lymphoma treated with low-dose radiotherapy: A single-center analysis of 155 patients
2025 · Yoon Sang Eun, Dongryul Oh, et al. · Blood
PDF
Integrated Omics to Dissect the Landscape in Chemosensitive and Refractory Extranodal Natural-Killer T-Cell Lymphoma (ENKTCL): A Global Study of the PETAL (PEripheral T-Cell Lymphoma) Consortium
2024 · Maria J. J. Fernandez Turizo, Yoonhee Nam, et al. · Blood
T-cell lymphoma:L ESMO Clinical Practice Guidelines for diagnosis, treatment, and follow up
2014 · D'Amore, Francesco Annibale, Gaulard, Philippe, et al.
The Clinical Findings of Gastrointestinal Burkitt Lymphoma in Adults
2008 · Jae-Hong Jung, Jun-Haeng Lee, et al. · Clinical Endoscopy
Works count: 12
Citation count: 1,643
H-index: 3
I10-index: 2
Year
Topic
Type